Graham K Cooper's Net Worth

$7.15 Million

Estimate Recalculated Nov 11, 2024 08:51AM EST

Who is Graham K Cooper?

Graham K Cooper has an estimated net worth of $7.15 Million. This is based on reported shares across multiple companies, which include Panacea Acquisition Corp, Orexigen Therapeutics, Inc., Receptos, Inc., Kezar Life Sciences, Inc., GERON CORP, Celladon Corp, Applied Molecular Transport Inc., Beam Therapeutics Inc., Unity Biotechnology, Inc., and ASSEMBLY BIOSCIENCES, INC..

SEC CIK

Graham K Cooper's CIK is 0001396943

Past Insider Trading and Trends

2021 was Graham K Cooper's most active year for acquiring shares with 7 total transactions. Graham K Cooper's most active month to acquire stocks was the month of May. 2009 was Graham K Cooper's most active year for disposing of shares, totalling 42 transactions. Graham K Cooper's most active month to dispose stocks was the month of November. 2014 saw Graham K Cooper paying a total of $255,000.00 for 96,945 shares, this is the most they've acquired in one year. In 2015 Graham K Cooper cashed out on 194,110 shares for a total of $39,632,441.55, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Panacea Acquisition Corp (NUVB) Snapshot price: $2.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
25K
—
—
25K
Feb 10
Form 3
—
0
—
—
0
No matching records found

Orexigen Therapeutics, Inc. No price found

CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Sep 20
Form 4
—
0
—
—
0
Jan 22
Form 4
-100.00%
-17.50K
$8.39
-$146,897.99
0
Dec 21
Form 4
∞
17.5K
$4.46
-$607,861.54
17.5K
Dec 21
Form 4
—
0
—
—
0
Apr 23
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
$6.35
-$93,326.70
0
Scheduled
Aug 21
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Dec 20
Form 4
—
0
$7.40
-$53,563.95
0
Scheduled
Dec 20
Form 4
—
0
$7.72
-$56,172.63
0
Scheduled
Nov 20
Form 3
—
0
—
—
0
No matching records found

Receptos, Inc. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-10.50K
—
—
0
Aug 27
Form 4
∞
10.5K
—
—
10.5K
Apr 1
Form 4
—
0
$33.20
-$2,810,000.00
0
Scheduled
Sep 16
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Jul 17
Form 3
—
0
—
—
0
No matching records found

Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.58

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jul 24
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found

GERON CORP (GERN) Snapshot price: $4.29

EVP, Bus Dev & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Jan 18
Form 3
—
0
—
—
0
No matching records found